JP2003052808A - Filtering method and device for liquid containing white corpuscle - Google Patents

Filtering method and device for liquid containing white corpuscle

Info

Publication number
JP2003052808A
JP2003052808A JP2001245283A JP2001245283A JP2003052808A JP 2003052808 A JP2003052808 A JP 2003052808A JP 2001245283 A JP2001245283 A JP 2001245283A JP 2001245283 A JP2001245283 A JP 2001245283A JP 2003052808 A JP2003052808 A JP 2003052808A
Authority
JP
Japan
Prior art keywords
leukocyte
blood
container
removal filter
containing liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001245283A
Other languages
Japanese (ja)
Inventor
Jun Tanaka
純 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP2001245283A priority Critical patent/JP2003052808A/en
Publication of JP2003052808A publication Critical patent/JP2003052808A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide filtering method and device capable of lowering pressure loss in filtration to enable high flow speed processing for the blood, and efficiently heightening the white corpuscle removing capability in the case of pressurizing and pouring the blood into a white corpuscle removing filter formed by a flexible container. SOLUTION: This white corpuscle removing filter is formed by a flexible container having an inlet and an outlet and a sheet-like white corpuscle removing filter material disposed to partition the interior of the container into the inlet side and the outlet side. In this filtering method for a liquid containing white corpuscle, the liquid containing white corpuscle is pressurized and poured from the inlet to be filtered at high flow speed with the above filter. A volume constraint plate disposed outside the inlet side and the outlet side of the flexible container is used to constrain the thickness of the white corpuscle removing filter, and at least the face of the volume constraint plate that is opposite to the outer surface on the outlet side of the container is provided with a groove connected to the outlet for a liquid containing white corpuscles. The depth of the groove is above 3 mm.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、白血球含有液から
凝集物や白血球等の好ましくない成分を除去する為の白
血球除去フィルターを用いて白血球含有液を濾過する方
法に関する。特に、可撓性容器からなる白血球除去フィ
ルターを使用してポンプなどを使用して高流速で白血球
含有液を濾過する場合に、白血球除去フィルターの膨ら
みを防止して白血球除去フィルターの厚みを適切に保持
し流れを均一にするための体積拘束板を使用した、白血
球含有液を濾過する方法に関する。
TECHNICAL FIELD The present invention relates to a method for filtering leukocyte-containing liquid using a leukocyte removal filter for removing undesirable components such as aggregates and leukocytes from leukocyte-containing liquid. In particular, when the leukocyte-containing filter composed of a flexible container is used to filter the leukocyte-containing liquid at a high flow rate using a pump or the like, the leukocyte-removing filter is prevented from bulging and the thickness of the leukocyte-removing filter is appropriately adjusted. The present invention relates to a method for filtering a leukocyte-containing liquid, which uses a volume restriction plate for holding and uniformizing the flow.

【0002】[0002]

【従来の技術】輸血の分野においては、血液製剤中に含
まれている混入白血球を除去してから血液製剤を輸血す
る、いわゆる白血球除去輸血が普及してきている。これ
は、輸血に伴う頭痛、吐き気、悪寒、非溶血性発熱反応
などの比較的軽微な副作用や、受血者に深刻な影響を及
ぼすアロ抗原感作、ウィルス感染、輸血後GVHDなどの重
篤な副作用が、主として輸血に用いられた血液製剤中に
混入している白血球が原因で引き起こされることが明ら
かにされたためである。
2. Description of the Related Art In the field of blood transfusion, so-called leukocyte-removing transfusion, in which contaminated leukocytes contained in a blood product are removed and then the blood product is transfused, has become widespread. This is due to relatively minor side effects such as headache, nausea, chills, non-hemolytic fever reaction associated with blood transfusion, severe alloantigen sensitization, virus infection, post-transfusion GVHD, etc., which seriously affects the recipient. This is because it has been clarified that such side effects are caused mainly by leukocytes contaminated in blood products used for blood transfusion.

【0003】白血球除去方法には、大きく分けて遠心分
離機を用いて血液成分の比重差を利用して白血球を分離
除去する遠心分離法と、繊維素材や、連続気孔を有する
多孔質体などの多孔質素子からなるフィルター材を用い
て白血球を除去するフィルター法の2種類がある。フィ
ルター法は、白血球除去能に優れていること、操作が簡
便であること、及びコストが安いことなどの利点を有す
るため現在普及している。
[0003] The leukocyte removal method is roughly classified into a centrifugal separation method in which leukocytes are separated and removed by utilizing a difference in specific gravity of blood components using a centrifuge, and a fibrous material and a porous body having continuous pores. There are two types of filter methods that remove white blood cells using a filter material composed of a porous element. The filter method is currently popular because of its advantages such as excellent leukocyte-removing ability, easy operation, and low cost.

【0004】フィルター法、即ち、白血球除去フィルタ
ーによる血液製剤などの白血球含有液の処理は、輸血操
作を行う際にベッドサイドで行われることが多かった
が、近年では白血球除去血液製剤の品質管理、及び白血
球除去処理の有効性向上の為に、血液センターにおいて
保存前に行われることが一般的になりつつある。
The filtering method, that is, the treatment of a leukocyte-containing liquid such as a blood product by a leukocyte-removing filter has often been performed at the bedside when performing a blood transfusion operation, but in recent years, quality control of leukocyte-removing blood products, Also, in order to improve the effectiveness of leukocyte removal treatment, it is becoming common to perform it before storage in a blood center.

【0005】従来白血球除去フィルターには、不織布や
多孔質体からなるフィルター要素をポリカーボネート等
の硬質容器に充填したものが広く使われてきたが、 1)容器がガス透過性を有さないため、採血分離セット
の滅菌工程として広く使われている蒸気滅菌を適用し難
い。 2)採血分離セットに白血球除去フィルターを組み込ん
だ、いわゆるクローズドシステムを使用し、全血を遠心
分離によって複数の血液成分に分離した後に白血球除去
を行う場合には、白血球除去フィルターも採血分離セッ
トと共に遠心されるため、この際、硬質の容器がバッグ
や導管にダメージを与えたり、硬質容器自身が遠心時の
ストレスに耐えられずに破損する可能性がある。などの
問題点を有するために、これらの問題点を解消する方法
として、可撓性素材を容器に用いた、可撓性の白血球除
去フィルターが開発されている。
Conventionally, a leukocyte-removing filter has been widely used in which a hard container such as polycarbonate is filled with a filter element made of a non-woven fabric or a porous body. 1) Since the container does not have gas permeability, It is difficult to apply steam sterilization, which is widely used as a sterilization process for blood collection sets. 2) When using a so-called closed system in which a leukocyte removal filter is incorporated into a blood collection / separation set and performing leukocyte removal after separating whole blood into a plurality of blood components by centrifugation, the leukocyte removal filter is also used with the blood collection / separation set. Since it is centrifuged, the hard container may damage the bag or the conduit at this time, or the hard container itself may not be able to withstand the stress during centrifugation and may be damaged. In order to solve these problems, a flexible leukocyte removal filter using a flexible material in a container has been developed.

【0006】通常これらの白血球除去フィルターで血液
を濾過する際は、濾過されるべき血液製剤が入ったバッ
グを、フィルターよりも100cm程高い位置に置き、重力
の作用によって血液製剤を濾過するのが一般的である。
Usually, when filtering blood with these leukocyte removal filters, the bag containing the blood product to be filtered is placed 100 cm higher than the filter and the blood product is filtered by the action of gravity. It is common.

【0007】しかし近年、市場においては白血球除去フ
ィルターに対する要求として、短時間で所望量の血液を
処理し作業時間を短縮化させたいといった要求がある。
このため、従来広く行われてきた重力の作用によって血
液製剤を濾過する方法の他に、ポンプなどで濾過する血
液を加圧し、白血球除去フィルターに流し込むことで血
液の濾過速度を大きくして、短時間で血液を濾過する方
法が検討されている。
However, in recent years, there is a demand in the market for a leukocyte removal filter to process a desired amount of blood in a short time to shorten the working time.
Therefore, in addition to the conventional method of filtering blood products by the action of gravity, the blood to be filtered is pressurized by a pump or the like and poured into a leukocyte removal filter to increase the blood filtration rate, Methods of filtering blood by time are being investigated.

【0008】このように、血液をポンプなどで加圧し可
撓性容器からなる白血球除去フィルターに流し込む濾過
方法を行った場合、濾過の最中に白血球除去フィルター
材の抵抗によって圧力損失が生じ、フィルター入口側の
空間が大きく陽圧となり容器は風船状に膨らみ、白血球
除去フィルター材と容器との接合部位に、該接合を剥が
そうとする力が常に加わり、白血球除去フィルターが破
裂する可能性があった。
[0008] As described above, when the filtration method of pressurizing blood with a pump or the like and flowing it into the leukocyte removal filter consisting of a flexible container is performed, a pressure loss occurs due to the resistance of the leukocyte removal filter material during the filtration, The space on the inlet side becomes large positive pressure and the container bulges like a balloon, and the force to peel off the joint is constantly applied to the joint part between the leukocyte removal filter material and the container, which may cause the leukocyte removal filter to burst. It was

【0009】このような破裂を防ぐ手段の一つに、可撓
性容器からなるフィルターを膨張した時の体積よりも小
さい容積のプラスチック等の補強箱またはカバーに収納
することにより耐圧性を高める方法が、WO90/156
60に開示されている。
As one of the means for preventing such rupture, a method of increasing the pressure resistance by housing a filter made of a flexible container in a reinforcing box or cover made of plastic or the like having a volume smaller than that when expanded But WO90 / 156
60.

【0010】しかし、このような補強箱に可撓性容器か
らなる白血球除去フィルターを収納し、血液をポンプな
どで加圧し可撓性容器からなる白血球除去フィルターに
流し込む濾過方法を行った場合、白血球除去フィルター
材の抵抗によって生じる圧力損失により、白血球除去フ
ィルター材は出口側の容器に押しつけられることにな
る。このような状態では、白血球除去フィルター材が出
口側容器と密着し、血液の流れが阻害される。
However, when a leukocyte removal filter composed of a flexible container is housed in such a reinforced box and blood is pressurized by a pump or the like to flow into the leukocyte removal filter composed of a flexible container, leukocytes are removed. Due to the pressure loss caused by the resistance of the removal filter material, the leukocyte removal filter material is pressed against the container on the outlet side. In such a state, the leukocyte removal filter material comes into close contact with the outlet side container, and the blood flow is obstructed.

【0011】また、特開2001−149444号公報
には、可撓性容器からなるフィルターを硬質ホルダーに
収納する発明が開示され、この硬質ホルダーでは、可撓
性容器と硬質ホルダーとの癒着を防止するために、ホル
ダー内面に幅が1mm〜3mm、間隔が2mm〜6m
m、高さ1mm〜3mmのリブなどの突起状物を設ける
ことが記載されている。しかし、本発明者がこの硬質ホ
ルダーを使用して、ポンプなどを使用して加圧して血液
を高流速で濾過しようとすると、白血球除去フィルター
材が押し付けられた出口側容器は、ホルダー内面に設け
られた複数のリブが作り出す隙間に膨張し進入するが、
白血球除去フィルター材と出口側容器との間に血液が高
流速で流れるのに十分な空間を作り出すには至らず、血
液の流れが阻害されることを防ぐことが困難であること
が分かった。
Further, Japanese Patent Application Laid-Open No. 2001-149444 discloses an invention in which a filter made of a flexible container is housed in a hard holder. In this hard holder, adhesion between the flexible container and the hard holder is prevented. In order to do so, the inner surface of the holder has a width of 1 mm to 3 mm and a space of 2 mm to 6 m.
It is described that a protrusion such as a rib having a height of m and a height of 1 mm to 3 mm is provided. However, when the present inventor uses this hard holder to pressurize using a pump or the like to filter blood at a high flow rate, the outlet side container on which the leukocyte removal filter material is pressed is provided on the inner surface of the holder. It expands and enters the gap created by the multiple ribs created,
It has been found that it is difficult to prevent the blood flow from being obstructed because a sufficient space for the blood to flow at a high flow rate cannot be created between the leukocyte removal filter material and the outlet side container.

【0012】フィルターの密着を解決する方法として、
フィルター材と出口側容器との間に連接棒と呼ばれる軟
質塩ビチューブを挿入して密着を防ぐ方法 (EP0526678)
や軟質容器内面に高低差0.2-2 mmの凹凸をつけて密着を
防ぐ方法(特開平11-216179号公報)、ニットファイバー
製のスクリーン等を挿入する方法(WO95/17236)等が開示
されている。これらに開示されている可撓性容器製白血
球除去フィルターをWO90/15660や特開2001
−149444号公報に開示されている補強箱やホルダ
ー内部に配置して、ポンプなどを使用して加圧して血液
を高流速で濾過した場合でも、白血球除去フィルター材
が出口側容器と密着してしまい、白血球除去フィルター
材と出口側容器との間に血液が流れるに十分な空間を作
り出すには至らず、血液の流れが阻害されることを防ぐ
ことが困難であることが分かった。
As a method of solving the filter adhesion,
A method to prevent adhesion by inserting a soft PVC tube called a connecting rod between the filter material and the outlet side container (EP0526678)
And a method of preventing the adhesion by making unevenness of height difference 0.2-2 mm on the inner surface of the soft container (JP-A-11-216179), a method of inserting a knit fiber screen or the like (WO95 / 17236) and the like are disclosed. There is. The leukocyte-removing filter made of a flexible container disclosed in these documents is used in WO90 / 15660 and Japanese Patent Laid-Open No. 2001.
No. 149444, the leukocyte-removing filter material is in close contact with the outlet-side container even when it is placed inside the reinforcing box or holder and the blood is filtered at a high flow rate by applying pressure using a pump or the like. It has been found that it is difficult to prevent the blood flow from being obstructed because a space sufficient for blood to flow cannot be created between the leukocyte removal filter material and the outlet side container.

【0013】また、特開平11-216179号公報に開示され
ている軟質容器内面に高低差0.2-2 mmの凹凸をつけて、
白血球除去フィルター材が出口側容器と密着することを
防ぐ方法においては、重力の作用によって血液製剤を濾
過するといった、比較的低圧で血液を濾過した場合に、
濾過時間の短縮に効果が認められるが、白血球除去能の
向上には効果が現れていない。
Further, the inner surface of the soft container disclosed in Japanese Patent Laid-Open No. 11-216179 has irregularities with a height difference of 0.2-2 mm,
In the method of preventing the leukocyte removal filter material from coming into close contact with the outlet side container, when the blood is filtered at a relatively low pressure such as filtering the blood product by the action of gravity,
Although effective in reducing the filtration time, it is not effective in improving leukocyte-removing ability.

【0014】以上のように、従来の技術では、短時間で
大量の血液を濾過するために、ポンプなどで加圧し可撓
性容器からなる白血球除去フィルターに流し込む高流速
濾過方法を行った場合、1)濾過時の圧力損失を低下さ
せ血液の高流速処理を可能とすること、2)白血球除去
能を効率よく高めること、を同時に達成することが困難
であった。
As described above, according to the conventional technique, in order to filter a large amount of blood in a short time, when a high flow rate filtration method is performed in which the fluid is pressurized by a pump or the like and poured into a leukocyte removal filter composed of a flexible container, It has been difficult to simultaneously achieve 1) reduction of pressure loss during filtration to enable high flow rate treatment of blood, and 2) efficient enhancement of leukocyte removal ability.

【0015】[0015]

【発明が解決しようとする課題】本発明の課題は、前記
のような問題点を解決することにあり、血液をポンプな
どで加圧し可撓性容器からなる白血球除去フィルターに
流し込む高流速濾過を行った場合、1)濾過時の圧力損
失を低下させ血液の高流速処理を可能とすること、2)
白血球除去能を効率よく高めること、を同時に達成する
ことにある。
SUMMARY OF THE INVENTION An object of the present invention is to solve the above-mentioned problems, in which high flow rate filtration in which blood is pressurized by a pump or the like and poured into a leukocyte removal filter composed of a flexible container is used. When performed, 1) to reduce the pressure loss during filtration to enable high-velocity blood treatment. 2)
Efficiently increasing the leukocyte-removing ability at the same time.

【0016】[0016]

【課題を解決する手段】本発明者は、上記課題を解決す
る血液濾過方法を鋭意検討した結果、少なくとも白血球
除去フィルターの血液出口側の外面に対向する面に、可
撓性容器からなる白血球除去フィルターの血液出口に向
かって連通する溝を有する板を用いて、可撓性容器から
なる白血球除去フィルターの厚みを拘束することによっ
て上記課題が解決できることを見出し、本発明に至っ
た。
Means for Solving the Problems As a result of intensive studies on a blood filtration method for solving the above problems, the present inventor has found that at least the surface of the leukocyte removal filter that faces the outer surface on the blood outlet side has a flexible container for removing leukocytes. The inventors have found that the above problems can be solved by restricting the thickness of a leukocyte removal filter composed of a flexible container by using a plate having a groove communicating with the blood outlet of the filter, and have reached the present invention.

【0017】すなわち、本発明は、入口と出口を有する
可撓性容器と、該容器内部を入口側と出口側とに隔てる
ように配置されたシート状の白血球除去フィルター材か
らなる白血球除去フィルターを用いて、白血球含有液を
入口から加圧して流し込み高流速で濾過する白血球含有
液の濾過方法において、可撓性容器の外側に配置され、
少なくとも出口側の容器外面に対向する面に、白血球含
有液出口に向かって連通する3mmを超える深さの溝を
有する体積拘束板を用いて、白血球除去フィルターの厚
みを拘束することを特徴とする白血球含有液の濾過方法
に関する。
That is, the present invention provides a leukocyte removal filter comprising a flexible container having an inlet and an outlet, and a sheet-shaped leukocyte removal filter material arranged so as to separate the inside of the container from the inlet side and the outlet side. In the method of filtering the white blood cell-containing liquid, which is applied by pressurizing the white blood cell-containing liquid from the inlet, and filtering at a high flow rate, the white blood cell-containing liquid is arranged outside the flexible container,
The thickness of the leukocyte-removing filter is constrained by using a volume constraining plate having a groove having a depth of more than 3 mm communicating with the leukocyte-containing liquid outlet at least on the surface facing the outer surface of the container on the outlet side. The present invention relates to a method for filtering a leukocyte-containing liquid.

【0018】本発明では、可撓性容器の外側に深さが3
mmを超え出口方向に向かって連通する溝を有する体積
拘束板を設けることによって、白血球含有液を加圧して
流し込み、高流速で濾過する場合においても、濾過時の
圧力損失を低下できて高流速を可能にし、白血球除去能
も高くすることができた。
In the present invention, a depth of 3 is provided outside the flexible container.
By providing a volume-constraining plate having a groove communicating with the outlet direction in excess of mm, even when the white blood cell-containing liquid is pressurized and poured in and filtered at a high flow rate, the pressure loss during filtration can be reduced and the high flow rate. It was possible to increase the leukocyte removal ability.

【0019】本発明は、また、加圧しながら高流速で濾
過する白血球含有液の濾過方法において好適に用いられ
る、深さが3mmを超え出口方向に向かって連通する溝
を有する体積拘束板、及び該体積拘束板を白血球除去フ
ィルターに組み合わせた濾過装置にも関するものであ
る。
The present invention also provides a volume constraining plate having a groove having a depth of more than 3 mm and communicating in the outlet direction, which is preferably used in a method of filtering a white blood cell-containing liquid which is filtered at a high flow rate while pressurizing. The present invention also relates to a filtration device in which the volume restriction plate is combined with a leukocyte removal filter.

【0020】[0020]

【発明の実施の形態】以下に、本発明について詳細に述
べる。本発明で濾過する白血球含有液としては、全血製
剤、赤血球製剤、血小板製剤、血漿製剤など、白血球を
含有する液であれば何れも適する。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention is described in detail below. As the white blood cell-containing liquid to be filtered in the present invention, any liquid containing white blood cells such as whole blood preparation, red blood cell preparation, platelet preparation and plasma preparation is suitable.

【0021】本発明で言う、可撓性容器製白血球除去フ
ィルターとは、血液の入口と出口を有する可撓性容器
と、該容器内部を白血球含有液の入口側と出口側とに隔
てるように配置されたシート状の白血球除去フィルター
材とからなる白血球除去フィルターであれば何れのフィ
ルターでも良く、例えば、特開平6-335516号公報、特開
平7-67952号公報、特開平7-267871号公報、特表平8-507
000号公報、特開平11-216179号公報、EP 0526678、WO9
0/15660などで開示されている可撓性容器製白血
球除去フィルターは何れも本発明に適する。シート状の
白血球除去フィルター材とは、メルトブロー法やフラッ
シュ紡糸法あるいは抄造法などによって製造された不織
布等の繊維構造物や、連続した細孔を有する多孔質体
(スポンジ状構造物)、多孔膜などが挙げられる。
The leukocyte-removing filter made of a flexible container referred to in the present invention comprises a flexible container having an inlet and an outlet for blood, and the inside of the container is separated into an inlet side and an outlet side of a leukocyte-containing liquid. Any filter may be used as long as it is a leukocyte removal filter composed of a sheet-shaped leukocyte removal filter material arranged, for example, JP-A-6-335516, JP-A-7-67952, JP-A-7-267871. , Tokuyoudaira 8-507
000, JP 11-216179, EP 0526678, WO9
The leukocyte-removing filter made of a flexible container disclosed in 0/15660 and the like is suitable for the present invention. The sheet-shaped leukocyte-removing filter material is a fibrous structure such as a non-woven fabric manufactured by a melt blow method, a flash spinning method or a papermaking method, a porous body having continuous pores (sponge-like structure), a porous membrane. And so on.

【0022】フィルター材を形成する基材が繊維繊維構
造物である場合、その素材としては、ポリアミド、ポリ
エステル、ポリアクリロニトリル、ポリトリフルオロエ
チレン、ポリメチルメタアクリレート、ポリスチレン、
ポリエチレン、ポリプロピレンなどが挙げられる。さら
に、繊維構造物を基材とする場合、ほぼ均一な繊維径を
有する繊維からなる基材であっても良いし、WO97/
23266に開示されているような、繊維径の異なる、
複数種の繊維が混繊された形態の基材であっても良い。
これらの繊維は平均繊維径が0.01μm以上3.0μ
m未満であるものが望ましい。
When the base material forming the filter material is a fiber fiber structure, its material is polyamide, polyester, polyacrylonitrile, polytrifluoroethylene, polymethylmethacrylate, polystyrene,
Examples thereof include polyethylene and polypropylene. Further, when the fibrous structure is used as the base material, it may be a base material composed of fibers having a substantially uniform fiber diameter.
23266, different fiber diameters, as disclosed in
It may be a base material in which a plurality of types of fibers are mixed.
These fibers have an average fiber diameter of 0.01 μm or more and 3.0 μm.
It is preferably less than m.

【0023】フィルター材を構成する基材が多孔質体あ
るいは多孔膜である場合、その素材としてはポリアクリ
ロニトリル、ポリスルホン、セルロースアセテート、ポ
リビニルホルマール、ポリエステル、ポリアクリレー
ト、ポリメタクリレート、ポリウレタンなど何れの素材
であっても本発明には適する。多孔質体あるいは多孔膜
の平均孔径は1μm以上30μm未満であるものが望ま
しい。また、フィルター材は基材そのものから構成して
も良いし、その表面を化学的あるいは物理的に改質した
ものでも良く、何れのフィルター材も白血球除去に寄与
しているシート状の白血球除去フィルター材に含まれ
る。フィルター材は、繊維構造物、多孔質体あるいは多
孔膜を単層で用いても良いし、複数層組み合わせて用い
ても良い。
When the base material constituting the filter material is a porous body or a porous membrane, the material can be any material such as polyacrylonitrile, polysulfone, cellulose acetate, polyvinyl formal, polyester, polyacrylate, polymethacrylate, and polyurethane. Even so, it is suitable for the present invention. The average pore size of the porous body or the porous film is preferably 1 μm or more and less than 30 μm. Further, the filter material may be composed of the base material itself, or the surface thereof may be chemically or physically modified, and any filter material contributes to leukocyte removal. A sheet-like leukocyte removal filter. Included in wood. The filter material may be a single layer of a fibrous structure, a porous material or a porous membrane, or may be a combination of a plurality of layers.

【0024】本発明において、加圧して白血球含有液を
白血球除去フィルターに流し込み、高流速で濾過すると
は、血液ポンプなどを用いて白血球含有液を加圧し、且
つ流速を高めて白血球フィルターに流し込んで濾過する
ことをいう。通常白血球除去フィルターで血液を処理す
る際に一般的に行われているような、処理されるべき血
液製剤が入ったバッグを、フィルターよりも100cm程高
い位置に置き、重力の作用によって血液製剤を濾過する
といった比較的低い負荷圧力での濾過、また、流速が5
0mL/分未満といった通常の血液濾過流速は、本発明
における加圧して血液を高流速で濾過することは異な
る。本発明において加圧して血液を高流速で濾過するに
は、血液ポンプなどを白血球除去フィルターと濾過され
るべき血液製剤が入ったバッグとの間に配置し、血液を
100mmHg〜400mmHgの圧力、流速50mL
/分〜200mL/分で白血球除去フィルターに送液す
るのが好ましい。
In the present invention, to pressurize the leukocyte-containing liquid to flow into the leukocyte-removing filter and to filter at a high flow rate means to pressurize the leukocyte-containing liquid using a blood pump or the like and to increase the flow velocity to flow into the leukocyte filter. Refers to filtering. Place the bag containing the blood product to be processed, which is generally used when treating blood with a leukocyte removal filter, at a position about 100 cm higher than the filter, and remove the blood product by the action of gravity. Filtration at a relatively low load pressure, such as filtration, and a flow rate of 5
Normal hemofiltration flow rates, such as less than 0 mL / min, differ from pressurizing and filtering blood at high flow rates in the present invention. To pressurize blood at a high flow rate in the present invention, a blood pump or the like is placed between the leukocyte removal filter and the bag containing the blood product to be filtered, and the blood pressure is 100 mmHg to 400 mmHg and the flow rate is 100 mmHg to 400 mmHg. 50 mL
It is preferable to transfer the solution to the leukocyte removal filter at a rate of from 200 to about 200 mL / min.

【0025】血液を100mmHg未満の圧力で加圧す
る場合、あるいは、流速が50mL/分未満の低流速で
濾過する場合は、加圧濾過しても白血球除去フィルター
の出口側可撓性容器の膨らみが小さく、血液が高流速で
流れるのに十分な空間が白血球除去フィルター材と出口
側可撓性容器との間に形成されない。このため濾過時の
圧力損失が大きくなり濾過する血液の流速がより小さく
なるので適さない。血液を400mmHgを超える圧力
で加圧する場合、あるいは、流速が200mL/分を超
える流速で濾過する場合は、赤血球膜の破壊などの有用
血液成分の破壊が起こる危険性があり適さない。
When blood is pressurized at a pressure of less than 100 mmHg, or when it is filtered at a low flow rate of less than 50 mL / min, the expansion of the flexible container on the outlet side of the leukocyte removal filter does not occur even if it is pressure filtered. A small space sufficient for blood to flow at a high flow rate is not formed between the leukocyte removal filter material and the outlet side flexible container. For this reason, the pressure loss during filtration increases and the flow rate of blood to be filtered becomes smaller, which is not suitable. When blood is pressurized at a pressure of more than 400 mmHg or is filtered at a flow rate of more than 200 mL / min, there is a risk of destruction of useful blood components such as destruction of red blood cell membrane, which is not suitable.

【0026】本発明の血液濾過方法で使用する体積拘束
板は、少なくとも白血球除去フィルターの白血球含有液
出口側の外面に対向する面に、白血球除去フィルターの
白血球含有液出口に向かって連通する3mmを超える深
さの溝を有する板である。体積拘束板は、白血球除去フ
ィルターの入口側と出口側との両方に、白血球除去フィ
ルターを挟み込むように配置されるのが好ましい。入口
側と出口側の2枚の体積拘束板はほぼ平行に向き合うよ
うに連結されていても良いが、バラバラの2枚を組み合
わせて用いても良い。2枚を組み合わせて用いるときに
は、白血球除去フィルターの厚みに応じて、2枚の向か
い合う体積拘束板の間に配置する、スペーサーを交換す
ることで容易に体積拘束板の間隔を調整できるので、よ
り望ましい。
The volume constraining plate used in the hemofiltration method of the present invention has at least 3 mm which is in communication with the leukocyte-containing liquid outlet of the leukocyte-removing filter on the surface of the leukocyte-removing filter facing the outer surface of the leukocyte-containing liquid outlet side. It is a plate having a groove having a depth exceeding the limit. The volume constraining plate is preferably arranged so as to sandwich the leukocyte removal filter on both the inlet side and the outlet side of the leukocyte removal filter. The two volume restraint plates on the inlet side and the outlet side may be connected so as to face each other substantially in parallel, but two separate pieces may be used in combination. When two sheets are used in combination, it is more desirable because the space between the volume constraining plates can be easily adjusted by exchanging spacers arranged between the two facing volume constraining plates according to the thickness of the leukocyte removal filter.

【0027】加圧して高流速で濾過するためには、溝の
深さは、3mmを超えることが必要である。3mm以下
であると、濾過時に白血球除去フィルター材が、出口側
可撓性容器に押し付けられるが、溝の深さが浅いため溝
の底面に接触してしまうので、可撓性容器が膨らむ領域
が制約されてしまう。その結果、血液が高流速で流れる
のに十分な空間が白血球除去フィルター材と出口側可撓
性容器との間に形成されず、濾過時の圧力損失が大きく
なり濾過する血液の流速が小さくなるので適さない。
In order to pressurize and filter at a high flow rate, the groove depth must exceed 3 mm. When it is 3 mm or less, the leukocyte removal filter material is pressed against the outlet side flexible container at the time of filtration, but since the groove is shallow, it comes into contact with the bottom surface of the groove, so that the area where the flexible container swells is small. You will be restricted. As a result, a sufficient space for the blood to flow at a high flow rate is not formed between the leukocyte removal filter material and the outlet side flexible container, resulting in a large pressure loss during filtration and a low flow rate of blood to be filtered. So not suitable.

【0028】溝の深さは6mm以下であることが好まし
い。6mmを超える場合は、不必要に体積拘束板の厚み
を厚くしなければならず、取扱性が悪くなるので望まし
くない。溝の深さが3mmを超えて5mm以下であるこ
とがより望ましい。
The depth of the groove is preferably 6 mm or less. If it exceeds 6 mm, the thickness of the volume constraining plate has to be unnecessarily increased, and the handleability is deteriorated, which is not desirable. More preferably, the groove depth is more than 3 mm and 5 mm or less.

【0029】少なくとも出口側の体積拘束板には、白血
球除去フィルターの白血球含有液出口に向かって連通す
る溝が出口側の外面に対向して形成されていることが必
要である。溝は体積拘束板全面に設けられていることが
好ましい。本発明において、溝が白血球含有液出口に向
かって連通するとは、溝に流入した液体が白血球含有液
出口に向かって集束して流れ込むことができるような状
態をいい、例えば、葉脈状や放射状の溝であることが望
ましい。連通していない溝が存在すると、その部分に血
液が滞留しやすく、その部分の白血球除去フィルター材
が有効に濾過に活用されなくなるという問題を生じてし
まう。
At least the outlet side volume restraint plate is required to have a groove communicating with the leukocyte-containing liquid outlet of the leukocyte removal filter facing the outer surface on the outlet side. The groove is preferably provided on the entire surface of the volume restraint plate. In the present invention, the fact that the groove communicates with the leukocyte-containing liquid outlet means a state in which the liquid that has flowed into the groove can be focused and flowed toward the leukocyte-containing liquid outlet, for example, a leaf vein or a radial shape. It is preferably a groove. If there is a groove that does not communicate with each other, blood tends to stay in that portion, which causes a problem that the leukocyte-removing filter material in that portion cannot be effectively utilized for filtration.

【0030】体積拘束板の大きさは、体積拘束する白血
球除去フィルターの有効濾過部分の80%以上の面積が
あることが好ましい。80%未満であると、体積拘束板
からはみ出た白血球除去フィルター部分が大きく膨ら
み、破裂する危険性があり好ましくない。体積拘束板の
大きさが、白血球除去フィルターよりも大きい場合は、
加圧によって白血球除去フィルターが大きく膨れること
が回避でき、耐圧性を高めるという点でも好ましい。体
積拘束板の材質は、加圧して白血球含有液を白血球除去
フィルターに流し込み、高流速で濾過する場合に白血球
除去フィルターが大きく膨れようとする圧力に耐え破損
しない強度を保つことができれば何れの材質であっても
良い。例えば、ポリカーボネート、アクリル、ポリスチ
レン、ポリプロピレン、硬質ポリ塩化ビニルなどの硬質
プラスチック、あるいは金属などの硬質材料が挙げられ
る。
The size of the volume-restricting plate is preferably 80% or more of the effective filtration portion of the leukocyte-removing filter for volume-restricting. If it is less than 80%, there is a risk that the leukocyte removal filter portion protruding from the volume restraint plate will largely swell and burst, which is not preferable. If the size of the volume restraint plate is larger than the leukocyte removal filter,
It is also preferable in that the leukocyte removal filter can be prevented from being greatly swollen by pressurization and the pressure resistance can be improved. The material of the volume restraint plate is any material as long as it can pressurize the leukocyte-containing liquid into the leukocyte removal filter and pressurize the leukocyte removal filter at a high flow rate to withstand the pressure that the leukocyte removal filter largely swells without breaking. May be Examples include hard plastics such as polycarbonate, acrylic, polystyrene, polypropylene, and hard polyvinyl chloride, and hard materials such as metals.

【0031】出口側体積拘束板に設ける溝の合計面積と
白血球除去フィルターの有効濾過部面積に対する面積の
比率、即ち出口側体積拘束板に設ける溝の占有面積比
は、0.30以上0.97以下であることが望ましい。
占有面積比が、0.30未満であると、加圧して白血球
含有液を高流速で濾過した場合、体積拘束板によって圧
迫され、白血球除去フィルター材が出口側容器と密着し
てしまう面積が大きく、高流速を達成するために必要
な、白血球除去フィルター材と出口側容器との間に血液
が流れるに十分な空間を作り出すには至らず、血液の流
速が小さくなるので適さない。さらに、体積拘束板によ
って圧迫される白血球除去フィルター材部分が多く、こ
の部分には血液が流れにくく、白血球除去には有効に活
用されにくい。その結果として白血球除去能が低下する
ので適さない。また、占有面積比が、0.97を超える
場合、体積拘束板に配置した溝の間隔が狭すぎ、加圧に
よって可撓性容器が体積拘束板に押し付けられた時に、
接触面積が小さすぎるため、可撓性容器に亀裂が入る危
険性が高いので適さない。溝の占有面積比は、0.40
以上0.93以下であることがより望ましく、0.45
以上0.90以下であることがさらに望ましい。
The ratio of the total area of the grooves provided on the outlet side volume restriction plate to the area of the effective filtration portion of the leukocyte removal filter, that is, the occupied area ratio of the grooves provided on the outlet side volume restriction plate is 0.30 or more and 0.97. The following is desirable.
If the occupied area ratio is less than 0.30, when the leukocyte-containing liquid is filtered at a high flow rate by pressurization, the area of the leukocyte-removing filter material that is pressed by the volume constraining plate and adheres to the outlet side container is large. However, it is not suitable because a sufficient space for blood to flow between the leukocyte-removing filter material and the outlet-side container necessary to achieve a high flow velocity cannot be created, and the flow velocity of blood is low. Furthermore, there are many leukocyte-removing filter material portions that are pressed by the volume-constraining plate, and it is difficult for blood to flow through these portions and it is difficult to effectively utilize them for leukocyte removal. As a result, the leukocyte-removing ability decreases, which is not suitable. Further, when the occupied area ratio exceeds 0.97, the intervals of the grooves arranged on the volume restraint plate are too small, and when the flexible container is pressed against the volume restraint plate by pressure,
Since the contact area is too small, there is a high risk of cracking in the flexible container, which is not suitable. Occupied area ratio is 0.40
It is more preferable that it is not less than 0.93 and not more than 0.45
It is more desirable to be 0.90 or less.

【0032】本発明の血液を加圧して高流速で濾過する
方法において使用する体積拘束板に設ける溝の幅は、3
mm以上15mm以下であることが望ましい。3mm未
満である場合、加圧濾過しても可撓性容器の膨らみが小
さく、血液が高流速で流れるのに十分な空間が白血球除
去フィルター材と出口側可撓性容器との間に形成されな
い。このため濾過時の圧力損失が大きくなり濾過する血
液の流速が小さくなるので適さない。溝の幅が15mm
を超える場合は、可撓性容器が膨らむと同時に、白血球
除去フィルター材が膨らんだ可撓性容器に密着するよう
に圧力によって押し付けられるため、白血球除去フィル
ター材と可撓性容器との間に血液が流れるのに十分な空
間が形成されないため、濾過時の圧力損失が大きくなり
濾過する血液の流速が小さくなるので適さない。溝の幅
が、4mm以上12mm以下であることがより望まし
く、5mm以上10mm以下であることが更に望まし
い。
The width of the groove provided in the volume constraining plate used in the method of pressurizing blood at a high flow rate of the present invention is 3
It is desirable that it is not less than 15 mm and not more than 15 mm. If it is less than 3 mm, the bulge of the flexible container is small even under pressure filtration, and a sufficient space for blood to flow at a high flow rate is not formed between the leukocyte removal filter material and the outlet side flexible container. . Therefore, the pressure loss at the time of filtration becomes large and the flow velocity of the blood to be filtered becomes small, which is not suitable. Groove width is 15 mm
If it exceeds, the leukocyte-removing filter material is pressed by pressure so that the leukocyte-removing filter material comes into close contact with the inflated flexible container at the same time as the flexible container swells. Is not suitable because a sufficient space for the flow of blood is not formed, resulting in a large pressure loss during filtration and a low flow rate of blood to be filtered. The width of the groove is more preferably 4 mm or more and 12 mm or less, and further preferably 5 mm or more and 10 mm or less.

【0033】溝と溝の間隔、すなわち、体積拘束板の溝
が形成されていない部分の幅は、0.5mm以上10m
m以下であることが望ましい。0.5mm未満である
と、加圧によって可撓性容器が体積拘束板に押し付けら
れた場合、接触面積が小さすぎるため、可撓性容器に亀
裂が入る危険性が高いので適さない。溝の間隔が10m
mを超える場合、体積拘束板によって圧迫される白血球
除去フィルター材の面積が多くなり、そのような部分は
実質濾過に活用されないため圧力損失も大きくなり、濾
過速度が小さくなると同時に、白血球除去能が低下する
ので適さない。溝の間隔が、2mm以上8mm以下であ
ることがより望ましく、3mm以上7mm以下であるこ
とがさらに望ましい。体積拘束板に設けられる溝の断面
形状は、矩形、半円、三角形など、どのような形状でも
良い。
The interval between the grooves, that is, the width of the portion of the volume restraint plate where the groove is not formed is 0.5 mm or more and 10 m.
It is preferably m or less. If it is less than 0.5 mm, when the flexible container is pressed against the volume constraining plate by pressurization, the contact area is too small and there is a high risk of cracking in the flexible container, which is not suitable. Distance between grooves is 10m
If it exceeds m, the area of the leukocyte-removing filter material that is compressed by the volume restraint plate increases, and such a portion is not utilized for the substantial filtration, so that the pressure loss also increases, the filtration rate decreases, and at the same time, the leukocyte-removing ability decreases. It is not suitable because it decreases. The groove interval is more preferably 2 mm or more and 8 mm or less, and further preferably 3 mm or more and 7 mm or less. The cross-sectional shape of the groove provided in the volume constraining plate may be any shape such as a rectangle, a semicircle, and a triangle.

【0034】入口側に使用される体積拘束板と出口側に
使用される体積拘束板の間隔は、[白血球除去フィルタ
ーの厚み−3mm]〜[白血球除去フィルターの厚み+
5mm]であることが望ましい。ここで言う白血球除去
フィルターの厚みとは、血液を濾過する前のフィルター
の外観の厚みを指す。入口側と出口側との体積拘束板の
間隔は、白血球除去フィルターの厚みより3mmを超え
て薄くした場合は、白血球除去フィルターの反発力が大
きく、フィルターを体積拘束板に挟むことが困難である
ため適さない。入口側と出口側との体積拘束板の間隔
が、白血球除去フィルターの厚みより5mmを超えて厚
くした場合は、濾過終了後、白血球除去フィルター内に
残留する血液量が多く、これを回収する操作が新たに必
要となり、煩雑な操作が増えると同時に、この操作に時
間を要するため望ましくない。また、白血球除去フィル
ター内に残留する血液量が多い場合は、生理食塩水など
でリンスして回収する際、残留する血液と回収に使用す
るリンス液との混合が起こり、残留する血液を効率良く
回収できないため望ましくない。入口側と出口側との体
積拘束板の間隔が、可撓性容器からなる白血球除去フィ
ルターの厚み−2.5mm〜+3mmの間隔であること
がより望ましく、白血球除去フィルターの厚み−2mm
〜+2mmの間隔であることが更に望ましい。
The interval between the volume restraint plate used on the inlet side and the volume restraint plate used on the outlet side is [thickness of leukocyte removal filter-3 mm] to [thickness of leukocyte removal filter +
5 mm] is desirable. The thickness of the leukocyte-removing filter mentioned here refers to the thickness of the appearance of the filter before filtering blood. When the distance between the inlet side and the outlet side of the volume restraint plate is smaller than the thickness of the leukocyte removal filter by more than 3 mm, the repulsive force of the leukocyte removal filter is large and it is difficult to sandwich the filter between the volume restraint plates. Not suitable for this. When the space between the inlet side and the outlet side is more than 5 mm thicker than the thickness of the leukocyte removal filter, there is a large amount of blood remaining in the leukocyte removal filter after the completion of filtration, and an operation to collect this Is newly required, and the number of complicated operations increases, and at the same time, this operation requires time, which is not desirable. Also, when there is a large amount of blood remaining in the leukocyte removal filter, when rinsing and recovering with physiological saline, etc., the remaining blood and the rinsing liquid used for recovery are mixed, and the remaining blood is efficiently removed. It is not desirable because it cannot be recovered. It is more preferable that the distance between the volume restriction plates on the inlet side and the outlet side is a distance of −2.5 mm to +3 mm of the leukocyte removal filter made of a flexible container, and the thickness of the leukocyte removal filter-2 mm.
It is more desirable that the interval is ˜ + 2 mm.

【0035】体積拘束板の溝は、白血球除去フィルター
の白血球含有液出口側の外面に対向する面だけでなく、
さらに白血球除去フィルターの入口側の外面に対向する
面にも設けた場合には、濾過時の圧力損失をさらに低下
させる、あるいは白血球除去能を高める効果が出口側の
外面に対向する面だけに使用した場合よりもより高いの
でより好ましい。
The groove of the volume constraining plate is not limited to the surface facing the outer surface of the leukocyte-removing filter on the outlet side of the leukocyte-containing liquid,
Furthermore, when it is also provided on the surface of the leukocyte removal filter that faces the outer surface on the inlet side, the effect of further reducing the pressure loss during filtration or increasing the leukocyte removal ability is used only on the surface that faces the outer surface on the outlet side. It is more preferable because it is higher than the case.

【0036】また、入口側に使用される体積拘束板と出
口側に使用される体積拘束板の間隔を、白血球除去フィ
ルターの厚みよりも小さくなるように設定することは、
濾過終了時の血液ロス量を低減させる目的において望ま
しい。
Further, it is necessary to set the interval between the volume restraint plate used on the inlet side and the volume restraint plate used on the outlet side so as to be smaller than the thickness of the leukocyte removal filter.
It is desirable for the purpose of reducing the amount of blood loss at the end of filtration.

【0037】次に、実施例により本発明をより詳細かつ
具体的に説明するが、本発明は、これらによって範囲を
限定されるものではない。
Next, the present invention will be described in more detail and specifically with reference to Examples, but the scope of the present invention is not limited by these.

【実施例1】血液の入口、出口を接着する部分に該入
口、出口の内径と同等以上の直径を有する孔を空けた厚
み0.04cmの可撓性のポリ塩化ビニル樹脂製シートと、内
径3mm、外径4.2mmの塩化ビニル製のチューブを、血液の
入口、出口にそれぞれ高周波溶着して、血液の入口の付
いた入口側の可撓性容器、及び、血液の出口の付いた出
口側の可撓性容器を作製した。
[Example 1] A flexible polyvinyl chloride resin sheet having a thickness of 0.04 cm, in which a hole having a diameter equal to or larger than the inner diameters of the inlet and the outlet is formed in a portion where the blood inlet and the outlet are bonded, and an inner diameter of 3 mm , A vinyl chloride tube with an outer diameter of 4.2 mm is welded to the blood inlet and outlet by high-frequency welding, respectively, and the flexible container on the inlet side with the blood inlet and the outlet side with the blood outlet are attached. A flexible container was made.

【0038】次に、以下に記すポリエステル製不織布を
積層して用いた。平均繊維径が12μm、目付が30g
/m2のもの(不織布(1))を4枚、平均繊維径1.
7μm、目付が66g/m2のもの(不織布(2))2
枚、平均繊維径1.2μm、目付が40g/m2のもの
(不織布(3))22枚、不織布(2)と同一のもの2
枚、不織布(1)と同一のもの4枚、合計34枚を積層
したものを、この順に積層した。以上のようにして作製
した、三種の不織布からなる積層物を130mm×13
0mm(正方形)に切断した。これらの可撓性容器と不
織布の積層体とを、入口側可撓性容器、不織布の積層
体、出口側可撓性容器の順に重ね合わせ、濾過部寸法が
103mm×103mmとなるように高周波溶着法を用い
て可撓性容器製白血球除去フィルターを作製した。な
お、血液入口側と出口側導管は、上記正方形型白血球除
去フィルターの対角線上に配置した。上記白血球除去フ
ィルターの厚みは、9.5mmであった。
Next, the following polyester non-woven fabrics were laminated and used. Average fiber diameter is 12μm and basis weight is 30g
/ M 2 (nonwoven fabric (1)) 4 pieces, average fiber diameter 1.
7 μm with a basis weight of 66 g / m 2 (nonwoven fabric (2)) 2
22 sheets, average fiber diameter 1.2 μm, and basis weight 40 g / m 2 (nonwoven fabric (3)) 22 sheets, same as nonwoven fabric (2) 2
A total of 34 sheets, which were the same as the nonwoven fabric (1), were laminated in this order. A laminate composed of three types of non-woven fabrics manufactured as described above was used as 130 mm × 13
It was cut to 0 mm (square). The flexible container and the nonwoven fabric laminate are superposed in this order on the inlet side flexible container, the nonwoven fabric laminate, and the outlet side flexible container, and high-frequency welding is performed so that the size of the filtration portion is 103 mm × 103 mm. A leukocyte-removing filter made of a flexible container was prepared by using the method. The blood inlet side and outlet side conduits were arranged on the diagonal line of the square type leukocyte removal filter. The leukocyte removal filter had a thickness of 9.5 mm.

【0039】上記の白血球除去フィルターを、濾過前血
液貯留バッグと濾過後血液回収バッグとの間に配置し、
濾過前血液貯留バッグに接続した入口側導管を白血球除
去フィルターの血液入口へ、濾過後血液回収バッグに接
続した出口側導管を白血球除去フィルターの血液出口へ
それぞれ接続した。また、それぞれの導管として、内径
3mm、外径4.2mmの塩化ビニル製のチューブを使用した。
入口側導管にY字管を取付け導管を介してデジタル圧力
計を取り付けた。また、濾過前血液貯留バッグとデジタ
ル圧力計につながるY字管との間に、血液を加圧送液す
るための血液ポンプを取り付けた。
The above leukocyte-removing filter is arranged between the blood storage bag before filtration and the blood collection bag after filtration,
The inlet-side conduit connected to the pre-filtration blood storage bag was connected to the blood inlet of the leukocyte removal filter, and the outlet-side conduit connected to the post-filtration blood collection bag was connected to the blood outlet of the leukocyte removal filter. Also, as each conduit,
A 3 mm vinyl chloride tube with an outer diameter of 4.2 mm was used.
A Y-tube was attached to the inlet side pipe, and a digital pressure gauge was attached via the pipe. Moreover, a blood pump for pressurizing and delivering blood was attached between the pre-filtration blood storage bag and the Y-shaped tube connected to the digital pressure gauge.

【0040】白血球除去フィルターの血液入口側の外面
に対向する体積拘束板の形状は次の通りである。17c
m×17cmのアクリル製の平面板に、4cm×4cm
の孔をあけ血液入口側導管周囲を圧迫しない構造とし
た。また、血液入口側導管が体積拘束板によって折り曲
げられたりしないように、体積拘束板の導管が接する個
所には、この導管に沿って幅5mm、深さ5mmの溝を
設けた。
The shape of the volume restraint plate facing the outer surface of the leukocyte removal filter on the blood inlet side is as follows. 17c
4 cm x 4 cm on an acrylic flat plate measuring mx 17 cm
The hole was opened to prevent pressure on the blood inlet side conduit. Further, in order to prevent the blood inlet side conduit from being bent by the volume constraining plate, a groove having a width of 5 mm and a depth of 5 mm was provided along the conduit at a position where the conduit of the volume restricting plate was in contact.

【0041】一方、白血球除去フィルターの血液出口側
の外面に対向する体積拘束板の形状は、血液入口側の外
面に接する体積拘束板と同じ形状のものに次に記す形状
の溝を設けたものである。血液出口側導管周囲を圧迫し
ない様に設けた4cm×4cmの孔に連通する、幅10
mm、深さ5mmの溝を対角線上に設けた。また、この
対角線上に設けた溝と45度の角度で連通する幅10m
m、深さ5mmの溝を5mmの間隔で体積拘束板全面に
葉脈状に設けた。出口側の体積拘束板に設置した溝の占
有面積比は、0.67であった。
On the other hand, the shape of the volume-constraining plate facing the outer surface on the blood outlet side of the leukocyte removal filter is the same as that of the volume-constraining plate in contact with the outer surface on the blood inlet side, with a groove having the following shape. Is. Width 10 that communicates with a 4 cm × 4 cm hole provided so as not to press around the blood outlet side conduit
A groove having a depth of 5 mm and a depth of 5 mm was provided on a diagonal line. Also, a width of 10 m that communicates with the groove provided on the diagonal line at an angle of 45 degrees.
Grooves with a depth of 5 mm and a depth of 5 mm were provided in a vein pattern on the entire surface of the volume constraining plate at intervals of 5 mm. The occupied area ratio of the grooves installed on the outlet side volume constraining plate was 0.67.

【0042】これら2枚の体積拘束板の間に白血球除去
フィルターを配置し、体積拘束板同士の間隔が9mmと
なるように固定した。なお、ここでいう体積拘束板同士
の間隔が9mmとは、血液出口側の外面に対向する体積
拘束板の溝と溝との間の凸部となっている先端部分と血
液入口側の外面に対向する体積拘束板との間隔である。
2枚の体積拘束板で拘束した白血球除去フィルターは、
血液入口側が下に、血液出口側が上になるように水平に
配置して血液を濾過した。
A leukocyte removal filter was placed between these two volume constraining plates and fixed so that the interval between the volume constraining plates was 9 mm. The interval between the volume restraint plates referred to herein is 9 mm on the outer surface on the blood inlet side and the tip portion that is the convex portion between the grooves of the volume restraint plate facing the outer surface on the blood outlet side. It is the distance from the facing volume constraining plate.
The leukocyte removal filter restrained by two volume restraint plates
Blood was filtered by horizontally arranging so that the blood inlet side was on the bottom and the blood outlet side was on the top.

【0043】400mLの牛血液に抗凝固剤として56
mLのACD−A液(組成:クエン酸ナトリウム22.
0g/L、クエン酸8.0g/L、グルコース22.0
g/L)を加えて調整した全血456mLを遠心分離し
た後、血漿及びバフィーコートを除去し、赤血球保存液
(組成:グルコース22.00g/L、塩化ナトリウム
9.00g/L、アデニン0.27g/L、マンニトー
ル7.50g/L)を加えた濃厚赤血球製剤(ヘマトク
リットは約60%)を調整し、20℃で20時間保存し
た。
56 as an anticoagulant in 400 mL of bovine blood
mL of ACD-A solution (composition: sodium citrate 22.
0 g / L, citric acid 8.0 g / L, glucose 22.0
456 mL of whole blood prepared by adding (g / L) was centrifuged, plasma and buffy coat were removed, and a red blood cell preservation solution (composition: glucose 22.00 g / L, sodium chloride 9.00 g / L, adenine 0. 27 g / L, mannitol 7.50 g / L) was added to prepare a concentrated red blood cell preparation (hematocrit is about 60%), and the mixture was stored at 20 ° C. for 20 hours.

【0044】上記の白血球除去フィルターに、濃厚赤血
球製剤721gを、流速100mL/分で濾過すること
により圧力損失の値と白血球除去性能を評価した。濃厚
赤血球製剤濾過中、濾過した血液50g毎にデジタル圧
力計の表示を記録し、最も高い圧力損失の値を記録し
た。濾過前血液貯留バッグ内の血液がなくなるまで濾過
を行い、濾過した血液を回収した。濾過前の濃厚赤血球
製剤(以下、濾過前液と言う)、及び回収された濃厚赤
血球製剤(以下、回収液と言う)の白血球濃度を求め、
これによって白血球除去能の比較を行った。
721 g of the concentrated red blood cell preparation was filtered through the above leukocyte removal filter at a flow rate of 100 mL / min to evaluate the pressure loss value and the leukocyte removal performance. During filtration of the concentrated red blood cell preparation, the digital pressure gauge display was recorded every 50 g of filtered blood, and the highest pressure loss value was recorded. Filtration was performed until the blood in the pre-filtration blood storage bag was exhausted, and the filtered blood was collected. Obtain the white blood cell concentration of the concentrated red blood cell preparation before filtration (hereinafter referred to as the pre-filtration liquid) and the recovered concentrated red blood cell preparation (hereinafter referred to as the recovery liquid),
Thereby, the leukocyte removal ability was compared.

【0045】濾過前液の白血球濃度は、チュルク液によ
って10倍希釈し、ビルケルチュルク型の血球計算盤に
注入して、光学顕微鏡を用いて白血球数をカウントする
ことによって測定した。また、回収液の白血球濃度の測
定は、以下に示す方法によって行った。回収液を、リュ
ーコプレート液(SOBIODA社製)にて5倍希釈す
る。希釈液をよく混和した後、室温にて6〜10分間放
置した。これを、2,750gで6分間遠心し、上清を
除去して液量を1.02gに調整した。この試料液をよ
く混和した後、ナジェット型の血球計算盤に注入し、光
学顕微鏡を用いて白血球数をカウントすることによって
白血球濃度を測定した。濾過終了後に白血球除去フィル
ター及び導管に残存する血液量を、濾過前後の白血球除
去フィルターの重量差から算出し、血液ロス量とした。
The white blood cell concentration of the pre-filtration solution was measured by diluting it 10-fold with Turk's solution, injecting it into a Birker-Turk type hemocytometer, and counting the number of white blood cells using an optical microscope. The white blood cell concentration of the recovered liquid was measured by the method described below. The recovered solution is diluted 5-fold with a Leuco plate solution (SOBIODA). After mixing the diluent well, it was left at room temperature for 6 to 10 minutes. This was centrifuged at 2,750 g for 6 minutes, the supernatant was removed, and the liquid volume was adjusted to 1.02 g. After thoroughly mixing this sample solution, it was injected into a Nadget-type hemocytometer, and the white blood cell concentration was measured by counting the number of white blood cells using an optical microscope. The amount of blood remaining in the leukocyte removal filter and the conduit after the completion of filtration was calculated from the weight difference between the leukocyte removal filter before and after filtration, and was taken as the blood loss amount.

【0046】[0046]

【比較例1】白血球除去フィルターの血液出口側の外面
に対向する体積拘束板に、血液入口側の外面に対向する
体積拘束板と同一形状のもの、すなわち溝を有さないも
のを使用した以外は実施例1と同じ白血球除去フィルタ
ーを使用し、同一の操作を行った。出口側の体積拘束板
に設置した溝の占有面積比は、0.0である。
[Comparative Example 1] Except that the volume constraining plate facing the outer surface on the blood outlet side of the leukocyte removal filter had the same shape as the volume constraining plate facing the outer surface on the blood inlet side, that is, one having no groove. The same operation was performed using the same leukocyte removal filter as in Example 1. The occupying area ratio of the grooves installed on the outlet side volume constraining plate is 0.0.

【0047】[0047]

【比較例2】白血球除去フィルターの血液出口側の外面
に対向する体積拘束板において、血液出口側導管周囲を
圧迫しない様に設けた4cm×4cmの孔に連通する、
幅6mm、深さ1.5mmの溝を対角線上に設けた。ま
た、この対角線上に設けた溝と45度の角度で連通する
幅10mm、深さ1.5mmの溝を5mmの間隔で体積
拘束板全面に葉脈状に設けた。即ち、実施例1で使用し
た、出口側体積拘束板の溝の深さを1.5mmとした以
外は実施例1と同一形状のものを使用し、実施例1と同
じ白血球除去フィルターを使用し、同一の操作を行っ
た。実施例1、比較例1および比較例2はそれぞれ同一
の濃厚赤血球製剤、すなわち、一旦プールした血液を分
割して濾過に使用し、同一の濃厚赤血球製剤を使用して
実施例1、比較例1および比較例2とを一組にして濾過
を行い、それぞれn=4評価を行った。濾過前液の白血
球濃度は、5,000から10,000個/μLの範囲
であった。また濾過中の圧力損失は、200から350
mmHgの範囲であった。それぞれn=4評価を行い、
結果を平均し、比較例1の結果を基準にして相対評価し
表1にまとめた。
[Comparative Example 2] A volume-constraining plate facing the outer surface of the leukocyte removal filter on the blood outlet side is communicated with a 4 cm × 4 cm hole provided so as not to press the circumference of the blood outlet side conduit.
A groove having a width of 6 mm and a depth of 1.5 mm was provided on a diagonal line. Further, grooves having a width of 10 mm and a depth of 1.5 mm, which communicate with the grooves provided on the diagonal line at an angle of 45 degrees, were provided in a vein pattern on the entire surface of the volume constraining plate at intervals of 5 mm. That is, the same shape as in Example 1 was used except that the depth of the groove of the outlet side volume restriction plate used in Example 1 was 1.5 mm, and the same leukocyte removal filter as in Example 1 was used. , The same operation was performed. In Example 1, Comparative Example 1 and Comparative Example 2, the same concentrated red blood cell preparation was used, that is, blood pooled once was divided and used for filtration, and the same concentrated red blood cell preparation was used in Example 1, Comparative Example 1 And Comparative Example 2 were combined as a set and filtered, and n = 4 was evaluated for each. The white blood cell concentration of the pre-filtration solution was in the range of 5,000 to 10,000 cells / μL. The pressure loss during filtration is 200 to 350.
It was in the range of mmHg. N = 4 evaluations each,
The results were averaged, and relative evaluation was performed based on the results of Comparative Example 1 and summarized in Table 1.

【0048】[0048]

【表1】 圧力損失比および回収液中の残存白血球濃度
[Table 1] Pressure loss ratio and residual white blood cell concentration ratio in the recovered liquid

【0049】以上の結果から、実施例1で使用した体積
拘束板を使用し、血液をポンプで加圧し可撓性容器から
なる白血球除去フィルターに流し込む高流速濾過方法を
行った場合、1)濾過時の圧力損失を低下させ血液の高
流速処理を可能とすること、及び2)白血球除去能を効
率よく高めることを同時に達成することができた。
From the above results, in the case of using the volume restraint plate used in Example 1 and performing the high flow rate filtration method in which blood is pressurized with a pump and poured into a leukocyte removal filter composed of a flexible container, 1) filtration At the same time, it was possible to reduce the pressure loss at the time to enable high flow rate treatment of blood, and 2) efficiently enhance leukocyte removal ability.

【0050】[0050]

【発明の効果】以上の通り、本発明の濾過方法、体積拘
束板及び濾過装置によれば、1)濾過時の圧力損失を低
下させ血液の高流速処理を可能とすること、2)白血球
除去能を効率よく高めることを同時に達成することがで
きた。
As described above, according to the filtration method, volume constraining plate and filtration device of the present invention, 1) it is possible to reduce the pressure loss during filtration and to process blood at a high flow rate, and 2) remove leukocytes. At the same time, we were able to achieve efficient performance enhancement.

Claims (10)

【特許請求の範囲】[Claims] 【請求項1】入口と出口を有する可撓性容器と、該容器
内部を入口側と出口側とに隔てるように配置されたシー
ト状の白血球除去フィルター材からなる白血球除去フィ
ルターを用いて、白血球含有液を入口から加圧して流し
込み高流速で濾過する白血球含有液の濾過方法におい
て、可撓性容器の入口側及び出口側の外側に配置された
体積拘束板を用いて白血球除去フィルターの厚みを拘束
し、該体積拘束板には少なくとも出口側の容器外面に対
向する面に、白血球含有液出口に向かって連通する溝を
設け、該溝の深さが3mmを超えることを特徴とする方
法。
1. A leukocyte using a flexible container having an inlet and an outlet, and a leukocyte removal filter comprising a sheet-shaped leukocyte removal filter material arranged so that the inside of the container is separated into an inlet side and an outlet side. In a method of filtering a leukocyte-containing liquid, which comprises pressurizing a contained liquid through an inlet and filtering it at a high flow rate, the thickness of the leukocyte-removing filter can be adjusted by using a volume constraining plate arranged outside the inlet side and the outlet side of the flexible container. A method of restraining, wherein the volume restraint plate is provided with a groove communicating with the white blood cell-containing liquid outlet at least on the surface facing the outer surface of the container on the outlet side, and the depth of the groove exceeds 3 mm.
【請求項2】100mmHg以上400mmHg以下の
圧力で白血球含有液を白血球除去フィルターに送液する
請求項1記載の白血球含有液の濾過方法。
2. The method for filtering a leukocyte-containing liquid according to claim 1, wherein the leukocyte-containing liquid is sent to a leukocyte removal filter at a pressure of 100 mmHg or more and 400 mmHg or less.
【請求項3】白血球含有液の流速が50mL/分以上2
00mL/分以下である請求項1または請求項2記載の
白血球含有液の濾過方法。
3. The leukocyte-containing liquid has a flow rate of 50 mL / min or more 2.
The method for filtering a leukocyte-containing liquid according to claim 1 or 2, which has a flow rate of 00 mL / min or less.
【請求項4】体積拘束板に設ける溝の占有面積比が、
0.30以上0.97以下である請求項1〜3のいずれ
かに記載の白血球含有液の濾過方法。
4. The occupied area ratio of the grooves provided in the volume restraint plate is
The method for filtering a leukocyte-containing liquid according to any one of claims 1 to 3, which is 0.30 or more and 0.97 or less.
【請求項5】体積拘束板に設ける溝の幅が、3mm以上
15mm以下である請求項1〜4のいずれかに記載の白
血球含有液の濾過方法。
5. The method for filtering a leukocyte-containing liquid according to claim 1, wherein the width of the groove provided on the volume constraining plate is 3 mm or more and 15 mm or less.
【請求項6】体積拘束板に設ける溝と溝の間隔が、0.
5mm以上10mm以下である請求項1〜5のいずれか
に記載の白血球含有液の濾過方法。
6. The space between the grooves provided on the volume constraining plate is 0.
The method for filtering a leukocyte-containing liquid according to any one of claims 1 to 5, which has a size of 5 mm or more and 10 mm or less.
【請求項7】体積拘束板に設ける溝の深さが、6mm以
下である請求項1〜6のいずれかに記載の白血球含有液
の濾過方法。
7. The method for filtering a leukocyte-containing liquid according to claim 1, wherein the depth of the groove provided in the volume restraint plate is 6 mm or less.
【請求項8】入口側に配置される体積拘束板と出口側に
配置される体積拘束板の間隔が、[白血球除去フィルタ
ーの厚み−3mm]〜[白血球除去フィルターの厚み+
5mm]である請求項1〜7のいずれかに記載の白血球
含有液の濾過方法。
8. The distance between the volume constraining plate disposed on the inlet side and the volume constraining plate disposed on the outlet side is [thickness of leukocyte removal filter-3 mm] to [thickness of leukocyte removal filter +
5 mm]. The method for filtering a leukocyte-containing liquid according to any one of claims 1 to 7.
【請求項9】入口と出口を有する可撓性容器と、該容器
内部を入口側と出口側とに隔てるように配置されたシー
ト状の白血球除去フィルター材からなる白血球除去フィ
ルターを用いて、白血球含有液を入口から加圧して流し
込み高流速で濾過する白血球含有液の濾過方法におい
て、容器外側に配置して使用される体積拘束板であっ
て、該容器の入口あるいは出口が貫通するための孔を有
し、且つ該孔に向かって連通する3mmを超える深さの
溝を有することを特徴とする体積拘束板。
9. A leukocyte using a flexible container having an inlet and an outlet, and a leukocyte removal filter comprising a sheet-like leukocyte removal filter material arranged so that the inside of the container is separated into an inlet side and an outlet side. A volume constraining plate used by being placed outside a container in a method for filtering a leukocyte-containing liquid in which a contained liquid is pressurized at an inlet and filtered at a high flow rate, and a hole through which an inlet or an outlet of the container penetrates. And a groove having a depth of more than 3 mm communicating with the hole.
【請求項10】入口と出口を有する可撓性容器と、該容
器内部を入口側と出口側とに隔てるように配置されたシ
ート状の白血球除去フィルター材からなる白血球除去フ
ィルター、及び、該容器外側に配置され、該容器の入口
あるいは出口が貫通するための孔を有し、該孔に向かっ
て連通する3mmを超える深さの溝を有する体積拘束板
からなり、白血球含有液を入口から加圧して流し込み高
流速で濾過するために用いる白血球含有液濾過装置。
10. A flexible container having an inlet and an outlet, a leukocyte removal filter comprising a sheet-like leukocyte removal filter material arranged so as to separate the inside of the container into an inlet side and an outlet side, and the container. It is a volume constraining plate that is arranged outside and has a hole through which the inlet or the outlet of the container penetrates, and has a groove with a depth of more than 3 mm that communicates toward the hole. A leukocyte-containing liquid filtration device used for pouring under pressure and filtering at a high flow rate.
JP2001245283A 2001-08-13 2001-08-13 Filtering method and device for liquid containing white corpuscle Withdrawn JP2003052808A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001245283A JP2003052808A (en) 2001-08-13 2001-08-13 Filtering method and device for liquid containing white corpuscle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001245283A JP2003052808A (en) 2001-08-13 2001-08-13 Filtering method and device for liquid containing white corpuscle

Publications (1)

Publication Number Publication Date
JP2003052808A true JP2003052808A (en) 2003-02-25

Family

ID=19075067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001245283A Withdrawn JP2003052808A (en) 2001-08-13 2001-08-13 Filtering method and device for liquid containing white corpuscle

Country Status (1)

Country Link
JP (1) JP2003052808A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709412B2 (en) 1999-09-03 2004-03-23 Baxter International Inc. Blood processing systems and methods that employ an in-line leukofilter mounted in a restraining fixture
US6875191B2 (en) 1999-09-03 2005-04-05 Baxter International Inc. Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter
US7041076B1 (en) 1999-09-03 2006-05-09 Baxter International Inc. Blood separation systems and methods using a multiple function pump station to perform different on-line processing tasks
JP2007244858A (en) * 2006-02-20 2007-09-27 Asahi Kasei Medical Co Ltd Method for filtering blood or blood component using leukocyte-removing filter and filter device
JP2008043895A (en) * 2006-08-18 2008-02-28 Asahi Kasei Kuraray Medical Co Ltd Granulocyte debinding material
US7655146B2 (en) 2006-02-20 2010-02-02 Asahi Kasei Medical Co., Ltd. Method for filtering blood or blood components using leukocyte-removing filter and filter device

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709412B2 (en) 1999-09-03 2004-03-23 Baxter International Inc. Blood processing systems and methods that employ an in-line leukofilter mounted in a restraining fixture
US6875191B2 (en) 1999-09-03 2005-04-05 Baxter International Inc. Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter
US7041076B1 (en) 1999-09-03 2006-05-09 Baxter International Inc. Blood separation systems and methods using a multiple function pump station to perform different on-line processing tasks
US7357897B2 (en) 1999-09-03 2008-04-15 Fenwal, Inc. Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter
US7517333B2 (en) 1999-09-03 2009-04-14 Baxter International Inc. Blood processing systems and methods that employ an in-line, flexible leukofilter
JP2007244858A (en) * 2006-02-20 2007-09-27 Asahi Kasei Medical Co Ltd Method for filtering blood or blood component using leukocyte-removing filter and filter device
US7655146B2 (en) 2006-02-20 2010-02-02 Asahi Kasei Medical Co., Ltd. Method for filtering blood or blood components using leukocyte-removing filter and filter device
JP2008043895A (en) * 2006-08-18 2008-02-28 Asahi Kasei Kuraray Medical Co Ltd Granulocyte debinding material
JP4683430B2 (en) * 2006-08-18 2011-05-18 旭化成クラレメディカル株式会社 Granulocyte remover

Similar Documents

Publication Publication Date Title
KR101038248B1 (en) Method of Removing Leukocytes, Leukocyte-Removing Filter and Utilization Thereof
US5298165A (en) Method for removing leukocytes and a filter system for removing the same
JP5048340B2 (en) Leukocyte removal method
US7655146B2 (en) Method for filtering blood or blood components using leukocyte-removing filter and filter device
JP2004130085A (en) Selective deleukocytation unit for platelet product
EP2659916B1 (en) Blood processing filter, blood circuit system, and centrifugation method
EP2878316B1 (en) Blood treatment filter, blood circuit, and blood treatment method
EP1016426A1 (en) Leukocyte-removing filter material
JP2003052808A (en) Filtering method and device for liquid containing white corpuscle
JP2007050013A (en) Method of removing leukocyte and leukocyte removing filter
WO1989002304A1 (en) Leucocyte-separating filter
JP4986285B2 (en) Filtration method and apparatus for blood or blood components using leukocyte removal filter
JP4188047B2 (en) Leukocyte-containing liquid filtration method and apparatus
JP3461359B2 (en) Leukocyte removal filter system and leukocyte removal method
JP4144709B2 (en) Leukocyte removal filter
JP4384823B2 (en) Leukocyte removal filter device and leukocyte removal method
TWI715998B (en) Filter material and manufacturing method thereof
JP5710244B2 (en) Blood processing filter
JP2006158738A (en) Centrifugal method of leukoreduction system
JP2005237791A (en) Method and system for filtering blood
JP2005204781A (en) Blood processing filter
JP4130401B2 (en) Blood treatment filter
JPH11290060A (en) Cell separation filter suitable for recovering cell, cell separation system and separation of cell
JP5749123B2 (en) Blood processing filter, blood processing system, and method for producing blood product
JPH01256971A (en) Leucocyte removing material and filter

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071106

A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20081104